BioSig Technologies

Ken Londoner, CEO of BioSig Technologies (NASDAQ: BSGM), was recently a guest on Benzinga’s All-Access BioSig is a digital signal processing company that has created the PURE EP Platform. The company unites expertise in medical engineering, intellectual property and workflow to deliver...

BioSig Technologies, Inc. (NASDAQ: BSGM) is a groundbreaking medical technology company that specializes in providing precision and accuracy in visualizing intracardiac signals. Recently, their subsidiary, BioSig AI Sciences, Inc. (BAIS), was chosen to join NVIDIA Inception. This prestigious...

BioSig Technologies, Inc. (NASDAQ: BSGM) announced a new collaboration agreement in June with Reified Labs, a technical advisory service specializing in advanced artificial intelligence (AI). Together, BioSig and Reified will research and develop an AI medical device platform with the potential to...

Cleveland Clinic researchers presented data from three new studies involving BioSig Technologies’ (NASDAQ: BSGM) proprietary PURE EP Platform at the annual Heart Rhythm 2023 meeting in New Orleans, LA last week. The platform’s precision signal-capturing technology is meant to improve...

This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. Arrhythmia is a heart condition that causes it to beat either too fast, or irregularly. It’s triggered by abnormal electrical activity and affects the...

Photo provided by BioSig The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. BioSig Technologies Inc. (NASDAQ: BSGM), a medical technology company commercializing an innovative signal-...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Image by PublicDomainPictures from Pixabay  An estimated 33.5 million individuals worldwide and nearly 2.7 million people in the U.S...

  The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Increasing its ever-growing presence in the cardiac electrophysiology space, BioSig Technologies (NASDAQ: BSGM) will be installing...

  The Company recently increased its procedural volume targets due to accelerated technology usage BioSig expands its commercial team to target technology adoption across three strategic regions   Westport, CT, June 30, 2021 /GLOBE NEWSWIRE/ — BioSig Technologies, Inc. (...

The Company sees increased technology usage across its installed base and anticipates enrolling to at least 1500 cases by the end of 2021 44 physicians have conducted over 800 arrhythmia patient cases to date Currently conducting patient cases in 9 medical centers across the country including...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. According to recent information published on WHO's 2019 Global Health Estimates, heart disease remains the leading cause of death...